Metoclopramide for Post Traumatic Headache
A Randomized Placebo Controlled Trial of IV Metoclopramide for Acute Post-traumatic Headache
Sponsor: Montefiore Medical Center
Listed as NCT03220958, this PHASE3 trial focuses on Post-Traumatic Headache and remains completed. Sponsored by Montefiore Medical Center, it has been updated 13 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE3
▶ Show 8 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Completed PHASE3
-
Sep 2021 — Dec 2021 [monthly]
Completed PHASE3
-
Jan 2021 — Sep 2021 [monthly]
Completed PHASE3
-
Jun 2020 — Jan 2021 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Jul 2019 — Jun 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jul 2019 [monthly]
Recruiting PHASE3
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE3
-
Aug 2017 — Dec 2017 [monthly]
Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Montefiore Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .